|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM26388855X |
| 003 |
DE-627 |
| 005 |
20231224204900.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231224s2016 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2016.08.018
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0879.xml
|
| 035 |
|
|
|a (DE-627)NLM26388855X
|
| 035 |
|
|
|a (NLM)27576056
|
| 035 |
|
|
|a (PII)S1521-6616(16)30311-4
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Olferiev, Mikhail
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus
|
| 264 |
|
1 |
|c 2016
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 12.05.2017
|
| 500 |
|
|
|a Date Revised 12.05.2017
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2016. Published by Elsevier Inc.
|
| 520 |
|
|
|a To gain novel insights into the immunopathogenesis of systemic lupus erythematosus we have analyzed gene expression data from isolated CD4+ T cells, CD8+ T cells, CD19+ B cells, and CD56+ NK-cell enriched peripheral blood cell fractions from patients and healthy donors. As predicted, type I interferon-inducible gene transcripts are overexpressed in all populations. Transcripts preferentially expressed in SLE CD4+ and CD8+ T cells include those associated with Tregulatory and Th17 effector cell programs, respectively, but in each case additional transcripts predicted to limit differentiation of those effector cells are detected. Evidence for involvement of the Wnt/β-catenin pathway was observed in both B and T cell fractions, and novel transcripts were identified in each cell population. These data point to disrupted T effector cell differentiation and the Wnt/β-catenin pathway as contributors to immune dysfunction in SLE while further supporting a central role for the type I interferon pathway in lupus
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Gene expression analysis
|
| 650 |
|
4 |
|a Microarray
|
| 650 |
|
4 |
|a Systemic lupus erythematosus
|
| 650 |
|
4 |
|a T effector cells
|
| 650 |
|
4 |
|a Type I interferon
|
| 650 |
|
4 |
|a Wnt/β-catenin
|
| 650 |
|
7 |
|a Interferon Type I
|2 NLM
|
| 700 |
1 |
|
|a Jacek, Elzbieta
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kirou, Kyriakos A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Crow, Mary K
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 172(2016) vom: 11. Nov., Seite 34-43
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:172
|g year:2016
|g day:11
|g month:11
|g pages:34-43
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2016.08.018
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 172
|j 2016
|b 11
|c 11
|h 34-43
|